FDA approves inhaled treprostinil for pulmonary hypertension associated with ILD ADD TOPIC TO EMAIL ALERTS Receive an email when new articles are posted on Please provide your email address to receive an email when new articles are posted on . Subscribe ADDED TO EMAIL ALERTS
You ve successfully added to your alerts. You will receive an email when new content is published.
Back to Healio
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.
Back to Healio
The FDA approved inhaled treprostinil for the treatment of patients with pulmonary hypertension associated with interstitial lung disease, according to a press release from United Therapeutics.
United Therapeutics Announces FDA Approval and Launch of Tyvaso® for the Treatment of Pulmonary Hypertension Associated with Interstitial Lung Disease
First and only approved therapy in the United States for patients with PH-ILD, a serious, life-threatening disease with potentially more than 30,000 patients in need
FDA approval based on data from the INCREASE clinical trial
PH-ILD is the second FDA-approved indication for Tyvaso, which was initially approved for the treatment of pulmonary arterial hypertension
News provided by
Share this article
Share this article
SILVER SPRING, Md. and RESEARCH TRIANGLE PARK, N.C., April 1, 2021 /PRNewswire/ United Therapeutics Corporation (Nasdaq: UTHR) today announced that the U.S. Food and Drug Administration (FDA) has approved Tyvaso
Series action continued at Woodbine Mohawk Park on Saturday (Dec. 19), with Rose Run Victory doubling up in the preliminaries while Man Dontforget Me ground to victory in the other division.
Rose Run Victory, off the 1-9 favourite, got away fourth to a :28 first quarter as Stevie Seelster swept past pylon-starter Docs Harmony to the lead. Driver Ed Hensley kept Rose Run Victory at the pegs to a :57.4 half while Classylaneprecious tipped first over from third. Hensley grabbed cover from Clasylaneprecious to the far turn and rolled three wide off three-quarters in 1:25.3 to charge past tiring horses to the front. The Shadow Play filly edged away to a two-and-three-quarter lengths win over Big Myrtle, who closed for second. Stevie Seelster slid into contention late to take third.